Engineered bacteriophages for treatment of a patient with a disseminated drug-resistant Mycobacterium abscessus.
Nat Med
; 25(5): 730-733, 2019 05.
Article
in En
| MEDLINE
| ID: mdl-31068712
ABSTRACT
A 15-year-old patient with cystic fibrosis with a disseminated Mycobacterium abscessus infection was treated with a three-phage cocktail following bilateral lung transplantation. Effective lytic phage derivatives that efficiently kill the infectious M. abscessus strain were developed by genome engineering and forward genetics. Intravenous phage treatment was well tolerated and associated with objective clinical improvement, including sternal wound closure, improved liver function, and substantial resolution of infected skin nodules.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Phage Therapy
/
Mycobacterium abscessus
/
Mycobacterium Infections, Nontuberculous
Limits:
Adolescent
/
Female
/
Humans
Language:
En
Journal:
Nat Med
Journal subject:
BIOLOGIA MOLECULAR
/
MEDICINA
Year:
2019
Document type:
Article
Affiliation country: